Screening Opportunities and Policy Updates in HCV

Video

Parvez Mantry, MD, examines the question of why so many patients with HCV do not undergo therapy. He also discusses policy updates aimed at improving screening and expanding access to treatment.

Related Videos
Stephen Congly, MD | Credit: University of Calgary
Taha Qazi, MD | Credit: Cleveland Clinic
Taha Qazi, MD | Credit: Cleveland Clinic
Taha Qazi, MD | Credit: Cleveland Clinic
Anthony Lembo, MD | Credit: Cleveland Clinic
Prashant Singh, MD | Credit: University of Michigan
Noa Krugliak Cleveland, MD | Credit: University of Chicago
Ali Rezaie, MD | Credit: X
Remo Panaccione, MD | Credit: University of Calgary
Francisca Joly, MD, PhD | Credit: The Transplantation Society
Related Content
Mitchel Shiffman, MD | Credit: Bon Secours

AHFIRM: Phase 2b Data Shows Promise for Larsucosterol in Alcohol-Associated Hepatitis

Abigail Brooks, MA
June 14th 2024
Article
Bindu Anand Balani, MD: Eradicating Hepatitis C Virus by 2030

Bindu Anand Balani, MD: Eradicating Hepatitis C Virus by 2030

Kenny Walter
July 28th 2022
Podcast
Eric Lawitz, MD | Credit: UT Health San Antonio

Bemnifosbuvir, Ruzasvir Combination Shows 97% SVR12 Rate in Phase 2 Trial for HCV

Abigail Brooks, MA
June 7th 2024
Article
What Ustekinumab Provides in Long-Term IBD Care

What Ustekinumab Provides in Long-Term IBD Care

Armand Butera
June 30th 2022
Podcast
Taha Qazi, MD | Credit: Cleveland Clinic

Qazi Corner, Edition 6: Bariatric Surgery in Liver Disease, Glucagon, and Cuffitis Outcomes

Taha Qazi, MD
June 6th 2024
Article
Joseph Carter Powers | Credit: Cleveland Clinic

Cuff Inflammation Following Pouch Creation and Future Stricture, Fistula Development

Joseph Carter Powers
June 6th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.